Francesca Barone, Chief Scientific Officer at Candel Therapeutics, Inc. (CADL), sold 27,068 shares at $7.23 ($196K) on 2025-01-15, disclosed to the SEC on 2025-01-17.
Open-market sale of $196k CADL by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.23 | 13,534 | $98K | 50.0% |
| 2 | $7.23 | 13,534 | $98K | 50.0% |
| Total | $7.23 avg | 27,068 | $196K | 100% |
| Filing → |
| CADL | SELL | 2025-01-10 | $225K | — | Filing → |
| CADL | SELL | 2024-12-03 | $201K | — | Filing → |
| CADL | SELL | 2024-07-19 | $182K | — | Filing → |